share_log

Mizuho Maintains Neutral on Amgen, Raises Price Target to $235

Benzinga ·  May 9 07:48

Mizuho analyst Salim Syed maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $223 to $235.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment